Strengthening of the intestinal epithelial tight junction by Bifidobacterium bifidum

Physiological Reports

Volumn 3, Issue 3, 2015, Pages

  Hsieh, Chen Yu ^a   Osaka, Toshifumi ^a   Moriyama, Eri ^a   Date, Yasuhiro ^b,c   Kikuchi, Jun ^b,c,d   Tsuneda, Satoshi ^a  

^a WASEDA UNIVERSITY   (Japan)

^b RIKEN Center for Sustainable Resource Science   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

1H NMR; Intestinal epithelial permeability; Metabonomics; Probiotics; Tight junctions

Indexed keywords

CLAUDIN 1; PROTEIN ZO1; TUMOR NECROSIS FACTOR;

ARTICLE; BIFIDOBACTERIUM BIFIDUM; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENTEROCOCCUS; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; ION CHROMATOGRAPHY; LACTOBACILLUS; METABOLOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; TIGHT JUNCTION;

EID: 84980413569     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12327     Document Type: Article

References (57)

1. Anderson, R. C., A. L. Cookson, W. C. McNabb, Z. Park, M. J. McCann, W. J. Kelly, et al. 2010. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol. 10:316-327.
2. Arrieta, M. C., L. Bistritz, and J. B. Meddings. 2006. Alterations in intestinal permeability. Gut 55:1512-1520.
3. Balda, M. S., and K. Matter. 2008. Tight junctions at a glance. J. Cell Sci. 121:3677-3682.
4. Balda, M. S., J. A. Whitney, C. Flores, S. Gonzalez, M. Cereijido, and K. Matter. 1996. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J. Cell Biol. 134:1031-1049.
5. Brown, A. J., S. M. Goldsworthy, A. A. Barnes, M. M. Eilert, L. Tcheang, D. Daniels, et al. 2003. The orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278:11312-11319.
6. Cario, E., G. Gerken, and D. K. Podolsky. 2004. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127:224-238.
7. Cario, E., G. Gerken, and D. K. Podolsky. 2007. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132:1359-1374.
8. Chikayama, E., E. Sekiyama, M. Okamoto, Y. Nakanishi, Y. Tsuboi, K. Akiyama, et al. 2010. Statistical indices for simultaneous large-scale metabolite detections for a single NMR spectrum. Anal. Chem. 82:1653-1658.
9. Date, Y., K. Sakata, and J. Kikuchi. 2012. Chemical profiling of complex biochemical mixtures from various seaweeds. J. Polymer 44:888-894.
10. De Vrese, M., and J. Schrezenmeir. 2008. Probiotics, prebiotics, synbiotics. Adv. Biochem. Eng. Biotechnol. 111:1-66.
11. Donato, K. A., M. G. Gareau, Y. J. J. Wang, and P. M. Sherman. 2010. Lactobacillus rhamnosus GG attenuates interferon-c and tumour necrosis factor-a-induced barrier dysfunction and pro-inflammatory signaling. Microbiology 156:3288-3297.
12. Elamin, E. E., A. A. Masclee, J. Dekker, H. J. Pieters, and D. M. Jonkers. 2013. Short-chain fatty acids activate AMPactivated protein kinase and ameliorate ethanol-induced intestinal barrier dysfunction in Caco-2 cell monolayers. J. Nutr. 143:1872-1881.
13. Ewaschuk, J. B., H. Diaz, L. Meddings, B. Diederichs, A. Dmytrash, J. Backer, et al. 2008. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G1025-G1034
14. Ferrier, L., F. Berard, L. Debrauwer, C. Chabo, P. Langella, L. Bueno, et al. 2006. Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am. J. Pathol. 168:1148-1154.
15. Franz, C. M. A. P., M. Huch, H. Abriouel, W. Holzapfel, and A. Gálvez. 2011. Enterococci as probiotics and their implications in food safety. Int. J. Food Microbiol. 151:125-140.
16. Galdeano, C. M., and G. Perdigon. 2006. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vaccine Immunol. 13:219-226.
17. Groschwitz, K. R., and S. P. Hogan. 2009. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin. Immunol. 124:3-20.
18. He, F., J. Peng, X. L. Deng, L. F. Yang, A. D. Camara, A. Omran, et al. 2012. Mechanisms of tumor necrosis factoralpha-induced leaks in intestine epithelial barrier. Cytokine 59:264-272.
19. Hoarau, C., C. Lagaraine, L. Martin, F. Velge-Roussel, and Y. Lebranchu. 2006. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J. Allergy Clin. Immun. 117:696-702.
20. Laukoetter, M. G., M. Bruewer, and A. Nusrat. 2006. Regulation of the intestinal epithelial barrier by the apical junctional complex. Curr. Opin. Gastroenterol. 22:85-89.
21. Ma, T. Y., M. A. Boivin, D. Ye, A. Pedram, and H. M. Said. 2005. Mechanism of TNF-a modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am. J. Physiol. Cell Physiol. 288: G422-G430
22. Ma, T. Y., G. K. Iwamoto, N. T. Hoa, V. Akotia, A. Pedram, M. A. Boivin, et al. 2006. TNF-a-induced increase in intestinal epithelial tight junction permeability requires NFjB activation. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G496-G504
23. Ma, X., M. Torbenson, A. R. Hamad, M. J. Soloski, and Z. Li. 2008. High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis. Clin. Exp. Immunol. 151:130-138.
24. Malago, J. J., J. F. Koninkx, P. M. Douma, A. Dirkzwager, A. Veldman, H. G. Hendriks, et al. 2003. Differential modulation of enterocyte-like Caco-2 cells after exposure to short-chain fatty acids. Food Addit. Contam. 20:427-437.
25. Maloy, K. J., and F. Powrie. 2011. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474:298-306.
26. Marchiand, A. M., W. V. Graham, and J. R. Turner. 2010. Epithelial barriers in homeostasis and disease. Annu. Rev. Pathol. 5:119-144.
27. Mariadason, J. M., D. H. Barkla, and P. R. Gibson. 1997. Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model. Am. J. Physiol. 272: G705-G712
28. Miyauchi, E., H. Morita, J. Okuda, T. Sashihara, M. Shimizu, and S. Tanabe. 2008. Cell wall fraction of Enterococcus hirae ameliorates TNF-α-induced barrier impairment in the human epithelial tight junction. Lett. Appl. Microbiol. 46:469-476.
29. Miyauchi, E., H. Morita, and S. Tanabe. 2009. Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo. J. Dairy Sci. 92:2400-2408.
30. Miyauchi, E., J. O’Callaghan, L. F. Buttó, G. Hurley, S. Melgar, S. Tanabe, et al. 2012. Mechanism of protection of transepithelial barrier function by Lactobacillus salivarius: strain dependence and attenuation by bacteriocin production. Am. J. Physiol. Gastrointest. Liver Physiol. 303: G1029-G1041
31. Mohamadzadeh, M., S. Olson, W. V. Kalina, G. Ruthel, G. L. Demmin, K. L. Warfield, et al. 2005. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl Acad. Sci. USA 102:2880-2885.
32. Noth, R., E. Stüber, R. Häsler, S. Nikolaus, T. Kühbacher, J. Hampe, et al. 2012. Anti-TNF-α antibodies improve intestinal barrier function in Crohn’s disease. J. Crohns. Colitis 6:464-469.
33. O’Hara, J. R., and A. G. Buret. 2008. Mechanism of intestinal tight junctional disruption during infections. Front Biosci. 112:266-274.
34. Ohland, C. L., and W. K. MacNaughton. 2010. Probiotic bacteria and intestinal epithelial barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 298:G807-G819
35. Oshima, T., H. Miwa, and T. Joh. 2008. Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7. Am. J. Physiol. Cell Physiol. 295: C800-C806
36. Patel, R. M., L. S. Myers, A. R. Kurundkar, A. Maheshwari, A. Nusrat, and P. W. Lin. 2012. Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am. J. Pathol. 180:626-635.
37. Putaala, H., T. Salusjarvi, M. Nordstrom, M. Saarinen, A. C. Ouwehand, E. Bech Hansen, et al. 2008. Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclooxygenase expression. Res. Microbiol. 159:692-698.
38. Resta-Lenert, S., and K. E. Barrett. 2003. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52:988-997.
39. Resta-Lenert, S., and K. E. Barrett. 2006. Probiotics and commensals reverse TNF-a-and IFN-c-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130:731-746.
40. Shen, L., E. D. Black, E. D. Witkowski, W. I. Lencer, V. Guerriero, E. E. Schneeberger, et al. 2006. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J. Cell Sci. 119:2095-2106.
41. Steck, N., M. Hoffmann, I. G. Sava, S. C. Kim, H. Hahne, S. L. Tonkonogy, et al. 2011. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology 141:959-971.
42. Suenaert, P., V. Bulteel, L. Lemmens, M. Noman, B. Geypens, G. Van Assche, et al. 2002. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease. Am. J. Gastroenterol. 97:2000-2004.
43. Sultana, R., A. J. McBain, and C. A. O’Neill. 2013. Straindependent augmentation of tight-junction barrier function in human primary epidermal keratinocytes by Lactobacillus and Bifidobacterium Lysates. Appl. Enviorn. Microbiol. 79:4887-4894.
44. Suzuki, T., S. Yoshida, and H. Hara. 2008. Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability. Br. J. Nutr. 100:297-305.
45. Targan, S. R., S. B. Hanauer, S. J. van Deventer, L. Mayer, D. H. Present, T. Braakman, et al. 1997. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for Crohn’s disease. N. Engl. J. Med. 337:1029-1035.
46. Tsukita, S., and M. Furuse. 2002. Claudin-based barrier in simple and stratified cellular sheets. Curr. Opin. Cell Biol. 14:531-536.
47. Turner, J. R., B. K. Rill, S. L. Carlson, D. Carnes, R. Kerner, R. J. Mrsny, et al. 1997. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am. J. Physiol. Cell Physiol. 273:C1378-C1385
48. Ulluwishewa, D., R. C. Anderson, W. C. McNabb, P. J. Moughan, J. M. Wells, and N. C. Roy. 2011. Regulation of tight junction permeability by intestinal bacteria and dietary components. J. Nutr. 141:769-776.
49. Van Deventer, S. J. 1997. Tumor necrosis factor and Crohn’s disease. Gut 40:443-448.
50. Van Itallie, C. M., and J. M. Anderson. 2006. Claudins and epithelial paracellular transport. Annu. Rev. Physiol. 68:403-429.
51. Ventura, M. T., L. Polimeno, A. C. Amoruso, F. Gatti, E. Annoscia, M. Marinaro, et al. 2006. Intestinal permeability in patients with adverse reactions to food. Dig. Liver Dis. 38:732-736.
52. Visser, J., J. Rozing, A. Sapone, K. Lammers, and A. Fasano. 2009. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann. N. Y. Acad. Sci. 1165:195-205.
53. Vogelsang, H., M. Schwarzenhofer, and G. Oberhuber. 1998. Changes in gastrointestinal permeability in celiac disease. Dig. Dis. 16:333-336.
54. Ye, D., I. Ma, and T. Y. Ma. 2006. Molecular mechanism of tumor necrosis factor-a modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G496-G504
55. Zeuthen, L. H., L. N. Fink, and H. Frøkiaer. 2008. Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells. Immunology 124:489-502.
56. Zolotarevsky, Y., G. Hecht, A. Koutsouris, D. E. Gonzalez, C. Quan, J. Tom, et al. 2002. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 123:163-172.
57. Zyrek, A. A., C. Cichon, S. Helms, C. Enders, U. Sonnenborn, and M. A. Schmidt. 2007. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKC zeta redistribution resulting in tight junction and epithelial barrier repair. Cell. Microbiol. 9:804-816.